US Patent Application 20100061928 - LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS
InventorsAssigneesUS Classes424/1.65, In an organic compound564/180, Polycyclo ring system in substituent Q546/316, Acyclic nitrogen bonded directly to the carbonyl546/121, Ring nitrogen is shared by the two cyclos546/169, Acyclic nitrogen bonded directly to the -C(=X)- group546/146, Having -C(=X)-, wherein X is chalcogen, attached directly or indirectly to the isoquinoline ring system by nonionic bonding544/355, Having -C(=X)-, wherein X is chalcogen, bonded directly to diazine ring carbon546/103, Chalcogen bonded directly to ring carbon of the six-membered hetero ring546/104Nitrogen, other than as nitro or nitroso, attached directly or indirectly to the acridine ring system by nonionic bondingAttorney, Agent or FirmForeign Documents
International ClassesA61K 51/04C07C 233/77 C07D 213/56 C07D 471/04 C07D 215/48 C07D 217/26 C07D 241/44 C07D 219/06 C07D 219/04 A61P 35/00 Abstract textThe present invention relates to the use of a compound of formula (I):
R2 and R3 represent, independently of one another, a hydrogen atom, a (C1-C6)alkyl group, a (C1-C6)alkenyl group or an aryl group chosen from a phenyl, benzyl, imidazolyl, pyridyl, pyrimidinyl, pyrazinyl, indolyl, indazolyl, furyl and thienyl group, and their addition salts with pharmaceutically acceptable acids, in the preparation of a radiopharmaceutical composition intended for the diagnosis and/or treatment of melanoma. |
| ||||||||||||||
